# Study of Postoperative ICC Analgesia

> **NCT04939545** · PHASE3 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 32 (actual)

## Conditions studied

- Postoperative Analgesia

## Interventions

- **DRUG:** Ropivacain
- **DRUG:** NaCl 0.9%

## Key facts

- **NCT ID:** NCT04939545
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-15
- **Primary completion:** 2023-03-20
- **Final completion:** 2023-10-20
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939545, "Study of Postoperative ICC Analgesia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04939545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*